Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scaled Biolabs is a biotechnology company that leverages proprietary microfluidic technology to accelerate the discovery and optimization of complex cell therapies and organoids. The company's platform enables high-throughput, massively parallel experimentation, allowing researchers to test thousands of unique cell culture conditions simultaneously. By automating the optimization of cell differentiation and expansion protocols, Scaled Biolabs helps partners reduce development timelines and improve the quality of advanced medicinal products. Their services are primarily utilized in the fields of regenerative medicine, oncology, and disease modeling.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scaled Biolabs.